首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Redox Interactions of Vitamin C and Iron: Inhibition of the Pro-Oxidant Activity by Deferiprone
【2h】

Redox Interactions of Vitamin C and Iron: Inhibition of the Pro-Oxidant Activity by Deferiprone

机译:维生素C和铁的氧化还原相互作用:去铁酮对前氧化剂活性的抑制作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ascorbic acid (AscH ) is one of the most important vitamins found in the human diet, with many biological functions including antioxidant, chelating, and coenzyme activities. Ascorbic acid is also widely used in medical practice especially for increasing iron absorption and as an adjuvant therapeutic in iron chelation therapy, but its mode of action and implications in iron metabolism and toxicity are not yet clear. In this study, we used UV–Vis spectrophotometry, NMR spectroscopy, and EPR spin trapping spectroscopy to investigate the antioxidant/pro-oxidant effects of ascorbic acid in reactions involving iron and the iron chelator deferiprone (L1). The experiments were carried out in a weak acidic (pH from 3 to 5) and neutral (pH 7.4) medium. Ascorbic acid exhibits predominantly pro-oxidant activity by reducing Fe to Fe , followed by the formation of dehydroascorbic acid. As a result, ascorbic acid accelerates the redox cycle Fe ↔ Fe in the Fenton reaction, which leads to a significant increase in the yield of toxic hydroxyl radicals. The analysis of the experimental data suggests that despite a much lower stability constant of the iron–ascorbate complex compared to the FeL1 complex, ascorbic acid at high concentrations is able to substitute L1 in the FeL1 chelate complex resulting in the formation of mixed L1 AscFe complex. This mixed chelate complex is redox stable at neutral pH = 7.4, but decomposes at pH = 4–5 during several minutes at sub-millimolar concentrations of ascorbic acid. The proposed mechanisms play a significant role in understanding the mechanism of action, pharmacological, therapeutic, and toxic effects of the interaction of ascorbic acid, iron, and L1.
机译:抗坏血酸(AscH)是人类饮食中发现的最重要的维生素之一,具有许多生物功能,包括抗氧化剂,螯合和辅酶活性。抗坏血酸还广泛用于医学实践中,尤其是用于增加铁的吸收并作为铁螯合疗法的辅助治疗剂,但是其作用方式以及对铁代谢和毒性的影响尚不清楚。在这项研究中,我们使用UV-Vis分光光度法,NMR光谱法和EPR自旋捕集光谱法研究了抗坏血酸在涉及铁和铁螯合剂去铁酮(L1)的反应中的抗氧化剂/促氧化剂作用。实验是在弱酸性(pH从3到5)和中性(pH 7.4)介质中进行的。通过将Fe还原为Fe,然后形成脱氢抗坏血酸,抗坏血酸主要表现出前氧化活性。结果,抗坏血酸在芬顿反应中加速了Fe cycle Fe的氧化还原循环,从而导致有毒羟基自由基的收率大大提高。对实验数据的分析表明,尽管铁-抗坏血酸络合物的稳定常数比FeL1络合物低得多,但高浓度的抗坏血酸仍能替代FeL1螯合物中的L1,从而形成混合的L1 AscFe络合物。这种混合的螯合物在中性pH = 7.4时是氧化还原稳定的,但在亚毫摩尔浓度的抗坏血酸下,在pH = 4–5的情况下会在几分钟内分解。所提出的机制在理解抗坏血酸,铁和L1相互作用的作用机理,药理,治疗和毒性作用方面起着重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号